top of page

KHIDI USA Update


KHIDI at a Glance in 2026
Introducing KHIDI, the Korea Health Industry Development Institute, dedicated to driving innovation and supporting the global advancement of Korea’s biohealth industry. From policy development and R&D to technology commercialization and global market expansion, KHIDI supports the entire innovation lifecycle and helps drive the growth of Korea’s biohealth industry. This brochure highlights KHIDI’s key roles, programs, and initiatives. Explore KHIDI’s vision, initiatives, and c


Connect & Development Day (9.3.2026)
Date: September 3rd (Thu) 2026, 10:00am - 03:00pm Location: The Foundry @ Cambridge Details: KHIDI USA and 45 K-Bio Innovators gathered for 'Connect & Development Day' to build stronger partnership. United by a shared ambition, we reinforced our dedication to leading the forefront of the global biomedical industry.


NEBS Coffee Hour (8.12.2026)
Date: 8.12.2026 (Wed) 12:00pm - 1:30pm Location: CIC Venture Cafe (5F)


UKC (US-Korea Conference) 2026 (8.5-8.8)
Topic: From Imagination to Innovation – Into Reality Date: August 5-8, 2026 Venue: Omni Orlando Resort Link: https://www.ukc.ksea.org/


KHIDI USA President: “For K-Bio to Succeed in the U.S., Clinical PoC Funding and Global Business Development Talent Are Essential”
By Hyun-woong Lee | San Diego(2026-06-27 14:38, The Munhwa Ilbo) “Global investors are no longer willing to invest based solely on the promise of platform technologies or their future potential.” Hyunchul Kim, President of the U.S. Office of the Korea Health Industry Development Institute (KHIDI), shared this assessment in an interview with Munhwa Ilbo during the BIO International Convention 2026, held this week in Boston. According to Kim, while global interest in Korean bio


KHIDI USA President: “Expanding Support for K-Bio Beyond Boston to the Entire United States”
Advanced Bio Innovation Hub to Serve as a Comprehensive Platform Connecting Industry, Academia, Research, and Healthcare By Sang-woo Roh | San Diego (2026-06-28 09:00, etoday) The Korea Health Industry Development Institute (KHIDI) is expanding its support system for Korean biotech companies beyond Boston to encompass the entire United States. Building upon its successful Boston model, KHIDI aims to evolve into a comprehensive platform that supports every stage of global mark


KHIDI Expands K-Bio’s U.S. East Coast Footprint with the “Boston Success Formula” (6.5.2026)
KHIDI Builds a Public-Private Partnership to Accelerate K-Bio’s Expansion into the U.S. Market Collaborating with KOTRA, Hallym University, SK Biopharmaceuticals, and the Korean American Society in Biotech and Pharmaceuticals (KASBP) As Korea’s biohealth exports continue to reach record highs, the Korea Health Industry Development Institute (KHIDI) is strengthening public-private partnerships to accelerate the successful entry of promising Korean biotech startups into the U.S
bottom of page